Super User, Author at BioHealth Innovation

Tomatoes were among the plants tested for sound by Tel Aviv University researchers. (David Besa, CC BY 2.0, Wikimedia Commons)

News

In groundbreaking research, Tel Aviv U team records plants ‘talking’ for first time | The Times of Israel

It has been known for some time that plants communicate with one…

Super UserApril 3, 2023

News

The AI genie is out of the bottle: Should it be crammed back inside?

By Tom Still MADISON, Wis. -- Society has been here many times…

Super UserApril 3, 2023

News

TEDCO’s Maryland Innovation Initiative Announced Recent Investments

$600,000 invested into 3 new ventures and $1.6Million awarded to 12 project…

Super UserMarch 30, 2023

Li SunGift Luncheon 01232023 SC 3754 1920x1080

News

From Serbia and China to College Park – Maryland Today

When husband and wife Zairen Sun Ph.D. ’98 and Beibei Li Ph.D.…

Super UserMarch 30, 2023

News

U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment

NARCAN® Naloxone HCl Nasal Spray 4 mg is currently the first and only…

Super UserMarch 30, 2023

News

Gaithersburg’s Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates

MARCH 28, 2023 - GAITHERSBURG, Md., (BUSINESS WIRE) -- Salubris Biotherapeutics, Inc.…

Super UserMarch 30, 2023

News

MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology

Leiden, the Netherlands , March 28, 2023 / B3C newswire / -- MIMETAS,…

Super UserMarch 30, 2023

BHI Weekly News Archives

551st Edition, March 28, 2023

Trouble Viewing This Email: Click Here March 28, 2023 FOUNDING MEMBER…

Super UserMarch 28, 2023

News

Exploring the Reversal of Cancer Resistance: A BioTalk Podcast Discussion with Vishal Doshi of AUM Biosciences

Ready to explore the frontiers of cancer therapeutics? Discover how AUM Biosciences,…

Super UserMarch 27, 2023

News

MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)

ROCKVILLE, MD, March 22, 2023 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical…

Super UserMarch 27, 2023

Super User

In groundbreaking research, Tel Aviv U team records plants ‘talking’ for first time | The Times of Israel

The AI genie is out of the bottle: Should it be crammed back inside?

TEDCO’s Maryland Innovation Initiative Announced Recent Investments

From Serbia and China to College Park – Maryland Today

U.S. FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ NARCAN® Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment

Gaithersburg’s Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates

MIMETAS and Astellas Enter into Strategic Partnership on Immuno-Oncology

551st Edition, March 28, 2023

Exploring the Reversal of Cancer Resistance: A BioTalk Podcast Discussion with Vishal Doshi of AUM Biosciences

MacroGenics Earns $15 Million Milestone Following U.S. FDA Approval of ZYNYZ™ (retifanlimab-dlwr)

About BioHealth Innovation

Contact

Connect